title: Attenuated temperature-sensitive respiratory syncytial virus mutants generated by cold adaptation.
abstract: Two strains of respiratory syncytial virus (RSV), RSV 2B and RSV 3A (representing subgroup B and A virus respectively) were cold-adapted by passaging in Vero cells for up to 42 weeks at successively lower temperatures down to 20 degrees C. Successful cold adaptation of the virus population was dependent on the amount of time the cultures were maintained at the various low temperatures, as well as on the strain of virus used. Temperature-sensitive (TS) mutants appeared in the cold passaged virus populations; however, the majority of the virus variants remained predominantly non-TS. Four RSV 2B and three RSV 3A TS mutants were selected for further characterization. These seven TS mutants retained their fusion phenotype and two major neutralizing antibody epitopes, and displayed varying levels of temperature sensitivity. Six of the seven mutants had a cold-adapted (CA) phenotype. All of the RSV 2B mutants were highly attenuated in cotton rats and two of the mutants elicited relatively high levels of neutralizing antibody and were able to protect rats against virus challenge. The RSV 3A TS mutants grew well in the nose but poorly in the cotton rat lungs, as did the parental 3A virus. All 3A mutants elicited high titers of neutralizing antibody and provided complete protection against virus challenge. These mutants showed varying levels of temperature sensitivity in vitro and attenuation in vivo and represent potential vaccine candidates.
authors.affiliation: Lederle-Praxis Biologicals, Pearl River, NY 10965.
authors.forename: V B
authors.initials: VB
authors.lastname: Randolph
authors.forename: M
authors.initials: M
authors.lastname: Kandis
authors.forename: P
authors.initials: P
authors.lastname: Stemler-Higgins
authors.forename: M S
authors.initials: MS
authors.lastname: Kennelly
authors.forename: Y M
authors.initials: YM
authors.lastname: McMullen
authors.forename: D J
authors.initials: DJ
authors.lastname: Speelman
authors.forename: C
authors.initials: C
authors.lastname: Weeks-Levy
mesh_terms: D000222:Adaptation, Physiological; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D002522:Chlorocebus aethiops; D003080:Cold Temperature; D006801:Humans; D008168:Lung / Q000821:virology; D009154:Mutation / Q000502:physiology*; D010641:Phenotype; D018357:Respiratory Syncytial Virus Infections / Q000276:immunology / Q000821:virology; D018113:Respiratory Syncytial Virus, Human / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity*; D012692:Serial Passage; D016205:Sigmodontinae; D013696:Temperature; D014420:Turbinates / Q000821:virology; D014613:Vaccines, Attenuated / Q000502:physiology*; D014709:Vero Cells; D014765:Viral Vaccines
chemical_list: D000914:Antibodies, Viral; D014613:Vaccines, Attenuated; D014765:Viral Vaccines